The following table shows the list of Horizon 2020 projects developed by "UCB BIOPHARMA SRL". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | TASPPI | H2020-EU.1.3.1. | participant | 0.00 | 2016-02-01 | 911 |
2 | ISOTOPICS | H2020-EU.1.3.1. | participant | 250˙560.00 | 2016-01-01 | 775 |
3 | RADAR-CNS | H2020-EU.3.1.7. | participant | 0.00 | 2016-04-01 | 860 |
4 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 0.00 | 2015-07-01 | 713 |
5 | DO-IT | H2020-EU.3.1.7. | participant | 0.00 | 2017-02-01 | 1037 |
6 | EQIPD | H2020-EU.3.1.7. | participant | 0.00 | 2017-10-01 | 808 |
7 | RTCure | H2020-EU.3.1.7. | participant | 0.00 | 2017-09-01 | 984 |
8 | PARADIGM | H2020-EU.3.1.7. | participant | 0.00 | 2018-03-01 | 603 |
9 | EFOEUPATI | H2020-EU.3.1.7. | participant | 0.00 | 2018-09-01 | 314 |
10 | GetReal Initiative | H2020-EU.3.1.7. | participant | 0.00 | 2018-06-01 | 319 |
11 | iConsensus | H2020-EU.3.1.7. | participant | 0.00 | 2018-05-01 | 336 |
12 | c4c | H2020-EU.3.1.7. | participant | 0.00 | 2018-05-01 | 394 |
13 | AIMS-2-TRIALS | H2020-EU.3.1.7. | participant | 0.00 | 2018-06-01 | 578 |
14 | EHDEN | H2020-EU.3.1.7. | participant | 0.00 | 2018-11-01 | 358 |
15 | ESCulab | H2020-EU.3.1.7. | participant | 0.00 | 2018-12-01 | 360 |
16 | NeuroDeRisk | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 318 |
17 | PD-MitoQUANT | H2020-EU.3.1.7. | participant | 0.00 | 2019-02-01 | 312 |
18 | BIOMAP | H2020-EU.3.1.7. | participant | 0.00 | 2019-04-01 | 336 |
19 | ConcePTION | H2020-EU.3.1.7. | participant | 0.00 | 2019-04-01 | 378 |
20 | EBiSC2 | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 378 |
21 | Trials@Home | H2020-EU.3.1.7. | participant | 0.00 | 2019-09-01 | 327 |
22 | INSPIRE | H2020-EU.1.3.1. | participant | 256˙320.00 | 2020-01-01 | 295 |
23 | IDEA-FAST | H2020-EU.3.1.7. | participant | 0.00 | 2019-11-01 | 338 |
24 | PharmaLedger | H2020-EU.3.1.7. | participant | 0.00 | 2020-01-01 | 409 |
totale | 506˙880.00 |
This organization collaborated with partners in 28 countries.
Within the project TASPPI this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | Celltech | CELLTECH R&D LIMITED (PRC) |
participant | DE | Taros Chemicals | TAROS CHEMICALS GMBH & CO KG (PRC) |
participant | DE | LDC | LEAD DISCOVERY CENTER GMBH (PRC) |
participant | IT | UNISI | UNIVERSITA DEGLI STUDI DI SIENA (HES) |
participant | CZ | CUNI | UNIVERZITA KARLOVA (HES) |
partner | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | UK | UNIVLEEDS | UNIVERSITY OF LEEDS (HES) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
coordinator | NL | TU/e | TECHNISCHE UNIVERSITEIT EINDHOVEN (HES) |
participant | FR | CNRS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (REC) |
Within the project ISOTOPICS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | FR | INSTN (HES) | |
partner | FR | LERMIT (HES) | |
partner | FR | Société de Chimie Thérapeutique (OTH) | |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
partner | FR | PSUD | UNIVERSITE PARIS-SUD (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | BE | UCB | UCB PHARMA SA (PRC) |
participant | BE | ULG | UNIVERSITE DE LIEGE (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
coordinator | FR | CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |
participant | FR | CNRS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (REC) |
Within the project RADAR-CNS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | STICHTING VUMC | STICHTING VUMC (REC) |
participant | CZ | MSD | MSD CZECH REPUBLIC SRO (PRC) |
participant | UK | BIOGEN | BIOGEN IDEC LIMITED (PRC) |
participant | UK | Intel | INTEL CORPORATION (UK) LIMITED (PRC) |
participant | DE | SAG | SOFTWARE AG (PRC) |
participant | ES | CIBER | CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (REC) |
participant | NL | LYGATURE | STICHTING LYGATURE (OTH) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | VHIR | FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (REC) |
participant | NL | IMEC-NL | STICHTING IMEC NEDERLAND (REC) |
participant | IT | UniBg | UNIVERSITA' DEGLI STUDI DI BERGAMO (HES) |
participant | DE | UNIA | UNIVERSITAET AUGSBURG (HES) |
participant | IT | IRCCS- FBF | PROVINCIA LOMBARDO VENETA - ORDINEOSPEDALIERO DI SAN GIOVANNI DI DIO- FATEBENEFRATELLI (REC) |
participant | US | NWU | NORTHWESTERN UNIVERSITY (HES) |
participant | DK | CRD | REGION HOVEDSTADEN (PUB) |
participant | DE | GABO:mi | GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG (PRC) |
participant | IT | USR | UNIVERSITA VITA-SALUTE SAN RAFFAELE (HES) |
participant | DE | UNI PASSAU | UNIVERSITAT PASSAU (HES) |
participant | DE | UKLFR | UNIVERSITAETSKLINIKUM FREIBURG (HES) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | UoN | THE UNIVERSITY OF NOTTINGHAM (HES) |
coordinator | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHA | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project ADAPT-SMART this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | FR | Lysogene | LYSOGENE (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project DO-IT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | HIQ | HEALTH IQ LIMITED (PRC) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | BE | EMSP | THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo | NOVO NORDISK A/S (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project EQIPD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Arlenda | PHARMALEX BELGIUM (PRC) |
participant | US | SE | SCIENCE EXCHANGE, INC. (PRC) |
participant | BE | Arlenda | ARLENDA SA (PRC) |
participant | DE | PAASP | PAASP GMBH (PRC) |
participant | NL | ECNP | STICHTING BURO ECNP (OTH) |
participant | US | PGI | PSYCHOGENICS INC (PRC) |
participant | US | ABBVIE | ABBVIE INC (PRC) |
participant | FR | Porsolt | PORSOLT SAS (PRC) |
participant | DE | UMC-Mainz | UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ (HES) |
participant | DE | concentris | Concentris Research Management GmbH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | NOLDUS | NOLDUS INFORMATION TECHNOLOGY BV (PRC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | NL | Sylics | SYNAPTOLOGICS BV (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | UK | UniAbdn | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (HES) |
participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
coordinator | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | CH | UBERN | UNIVERSITAET BERN (HES) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project RTCure this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | SE | ANOCCA | ANOCCA AB (PRC) |
participant | BE | API | APITOPE INTERNATIONAL NV (PRC) |
participant | DE | DRFZ | Deutsches Rheuma-Forschungszentrum Berlin (REC) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | IRB | FONDAZIONE PER L ISTITUTO DI RICERCA IN BIOMEDICINA (REC) |
participant | HU | SEMMELWEIS | SEMMELWEIS EGYETEM (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | AU | UQ | THE UNIVERSITY OF QUEENSLAND (HES) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | UK | UGLA | UNIVERSITY OF GLASGOW (HES) |
coordinator | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
Within the project PARADIGM this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Alexion | ALEXION SERVICES EUROPE SPRL (PRC) |
participant | CA | HTAi | HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY (OTH) |
participant | BE | Synergist | THE SYNERGIST (OTH) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | NL | STICHTING VU | STICHTING VU (HES) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | LU | AE | ALZHEIMER EUROPE (OTH) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | IACS | INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (REC) |
participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
coordinator | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project EFOEUPATI this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | IE | IPPOSI | IRISH PLATFORM FOR PATIENTS' ORGANISATIONS SCIENCE AND INDUSTRY LIMITED BY GUARANTEE (OTH) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
coordinator | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
Within the project GetReal Initiative this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | UK | IAPO | INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS (OTH) |
participant | BE | VT | VITAL TRANSFORMATION (PRC) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | UK | TAKEDA | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | NL | Astellas | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | FR | LA-SER | L.A SANTE, EPIDEMIOLOGIE, EVALUATION ET RECHERCHE L.A.S.E.R. (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
Within the project iConsensus this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | RB | RENTSCHLER BIOPHARMA SE (PRC) |
participant | NL | KAN | KANTISTO BV (PRC) |
participant | DE | PAIA | PAIA BIOTECH GMBH (PRC) |
participant | BE | ITC | IPRATECH SA (PRC) |
participant | DK | SVA | SVANHOLM.COM APS (PRC) |
participant | NL | SYNTHON | SYNTHON BIOPHARMACEUTICALS BV (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | FR | ISE | IPRASENSE (PRC) |
participant | DE | M2P | M2P-LABS GMBH (PRC) |
participant | NL | MICRONIT | MICRONIT MICROTECHNOLOGIES BV (PRC) |
participant | BE | UMONS | UNIVERSITE DE MONS (HES) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | DE | PS | PRESENS PRECISION SENSING GMBH (PRC) |
participant | DE | UHOH | UNIVERSITAET HOHENHEIM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DE | RWTH | RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN (HES) |
coordinator | SE | KTH | KUNGLIGA TEKNISKA HOEGSKOLAN (HES) |
Within the project c4c this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | HU | MCRN-Hungary | GYERMEKGYOGYASZATI KLINIKAI VIZSGALOI HALOZAT (OTH) |
participant | DE | HSK | HELIOS DR. HORST SCHMIDT KLINIKEN WIESBADEN GMBH (PRC) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | AT | OKIDS | OKIDS GMBH (OTH) |
participant | NL | ECAPN-ECNP | ECNP RESEARCH AND SCHOLARSHIP STICHTING (DE ECNP RESEARCH AND SCHOLARSHIP FOUNDATION) (OTH) |
participant | DK | ECFS | EUROPEAN CYSTIC FIBROSIS SOCIETY (OTH) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | IT | FGB | FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS (REC) |
participant | CH | SCTO | SWISS CLINICAL TRIAL ORGANISATION (OTH) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | IT | ARSENAL | ARSENAL.IT - CENTRO VENETO RICERCAE INNOVAZIONE PER LA SANITA DIGITALE (REC) |
participant | ES | CHUS | SERVIZO GALEGO DE SAUDE (PUB) |
participant | NO | HUS-Norway | HELSE BERGEN HF*HAUKELAND UNIVERSITY HOSPITAL (HES) |
participant | PT | AIDFM | Associação para Investigação e Desenvolvimento da Faculdade de Medicina (HES) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | SERVIER | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | BE | SIOPE | SIOP EUROPE ASBL (OTH) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DE | RBMF | ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH (REC) |
participant | IT | OPBG | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | IT | IGG | ISTITUTO GIANNINA GASLINI (PUB) |
participant | FI | HUS | HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ (REC) |
participant | PL | IPCZD | INSTYTUT POMNIK CENTRUM ZDROWIA DZIECKA (REC) |
coordinator | IT | PENTA | FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS (REC) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | DE | UKL-HD | UNIVERSITATSKLINIKUM HEIDELBERG (HES) |
participant | EE | UT | TARTU ULIKOOL (HES) |
participant | EL | AUTH | ARISTOTELIO PANEPISTIMIO THESSALONIKIS (HES) |
participant | CZ | CUNI | UNIVERZITA KARLOVA (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | IE | Tyndall - UCC | UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | UNILIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | BE | UGent | UNIVERSITEIT GENT (HES) |
participant | NL | SKU | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project AIMS-2-TRIALS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | SFARI | THE SIMONS FOUNDATION, INC (REC) |
participant | UK | Autistica | AUTISTICA (OTH) |
participant | ES | FPGF | FUNDAZIOA POLICLINICA GIPUZKOA FUNDACION (OTH) |
participant | IL | Teva | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | NL | ECNP | STICHTING BURO ECNP (OTH) |
participant | US | AUTISM SPEAKS | AUTISM SPEAKS INC. NON PROFIT CORPORATION (OTH) |
participant | BE | AE | AUTISME-EUROPE AISBL (OTH) |
participant | FR | CHUT | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS (HES) |
participant | BE | BIOSCI | BIOSCI CONSULTING BVBA (PRC) |
participant | PT | UCoimbra | UNIVERSIDADE DE COIMBRA (HES) |
participant | IT | FSM | Fondazione Stella Maris (REC) |
participant | NL | DEMCON | DEMCON ADVANCED MECHATRONICS ENSCHEDE B.V. (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | NOLDUS | NOLDUS INFORMATION TECHNOLOGY BV (PRC) |
participant | ES | FCRB | FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA (REC) |
participant | ES | SERMAS | SERVICIO MADRILENO DE SALUD (PUB) |
participant | DE | UMG-GOE | UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS (HES) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | ES | STARLAB | STARLAB BARCELONA SL (PRC) |
participant | FR | ARTTIC | ARTTIC (PRC) |
participant | UK | BC | BIRKBECK COLLEGE - UNIVERSITY OF LONDON (HES) |
participant | IE | TCD | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (HES) |
participant | ES | USAL | UNIVERSIDAD DE SALAMANCA (HES) |
participant | DE | TUM-MED | KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN (HES) |
participant | ZA | SU | STELLENBOSCH UNIVERSITY (HES) |
participant | DE | UULM | UNIVERSITAET ULM (HES) |
participant | DE | CIMH | ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT (HES) |
participant | CH | UNIBAS | UNIVERSITAT BASEL (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | UNIGLAS | UNIVERSITY OF GLASGOW (HES) |
participant | UK | UNI OF BRISTOL | UNIVERSITY OF BRISTOL (HES) |
participant | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | DE | IAP | JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN (HES) |
coordinator | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | BE | UGENT | UNIVERSITEIT GENT (HES) |
participant | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | FR | CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |
participant | FR | IPP | INSTITUT PASTEUR (REC) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project EHDEN this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CZ | Odysseus | ODYSSEUS DATA SERVICES SRO (PRC) |
participant | UK | ICHOM | INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT LTD (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | US | ABBVIE | ABBVIE INC (PRC) |
participant | NL | THE HYVE | THE HYVE BV (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | SE | UMC | Stiftelsen WHO Collaborating Centre for International Drug Monitoring (REC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | PT | UAVR | UNIVERSIDADE DE AVEIRO (HES) |
participant | EE | TARTU | TARTU ULIKOOL (HES) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
coordinator | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project ESCulab this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | NL | MTR | MERCATORIAL BV (PRC) |
participant | NL | MLD | MERCALEADS BV (PRC) |
participant | UK | BSC | BIOASCENT DISCOVERY LIMITED (PRC) |
participant | NL | PPSC | PIVOT PARK SCREENING CENTRE BV (REC) |
participant | DE | TRS | TAROS CHEMICALS GMBH & CO KG (PRC) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | FR | EDL | EDELRIS SAS (PRC) |
participant | UK | SYG | SYGNATURE DISCOVERY LIMITED (PRC) |
participant | CH | MMV | Medicines for Malaria Venture (REC) |
coordinator | NL | LYG | STICHTING LYGATURE (OTH) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | SCM | SYNCOM BV (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | FR | IdRS | INSTITUT DE RECHERCHES SERVIER (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project NeuroDeRisk this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | FCDI | FUJIFILM CELLULAR DYNAMICS INC (PRC) |
participant | FR | UCA | UNIVERSITE CLERMONT AUVERGNE (HES) |
participant | RS | UNIBEO | FARMACEUTSKI FAKULTET UNIVERZITETAU BEOGRADU (HES) |
participant | FR | ALCEDIAG | ALCEDIAG (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | EL | BIOVISTA | A. PERSIDIS & SIA OE (PRC) |
participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | PT | ICETA | ICETA INSTITUTO DE CIENCIAS, TECNOLOGIAS E AGROAMBIENTE DA UNIVERSIDADE DO PORTO (REC) |
participant | AT | IL | INTE:LIGAND SOFTWARE-ENTWICKLUNGS-UND CONSULTING GMBH (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
coordinator | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
participant | IT | CRIACIV LABIMA | UNIVERSITA DEGLI STUDI DI FIRENZE (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
Within the project PD-MitoQUANT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | IL | Teva | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | UK | PUK | PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG (OTH) |
participant | NL | Mimetas | MIMETAS BV (PRC) |
participant | DE | DZNE | DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV (REC) |
participant | FR | ICM | INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE (REC) |
participant | DE | GENEXPLAIN | GENEXPLAIN GMBH (PRC) |
participant | IE | PT | PINTAIL LTD (PRC) |
coordinator | IE | RCSI | ROYAL COLLEGE OF SURGEONS IN IRELAND (HES) |
participant | DK | LUNDBECK | H. LUNDBECK AS (PRC) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | IT | CNR | CONSIGLIO NAZIONALE DELLE RICERCHE (REC) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | FR | CNRS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (REC) |
Within the project BIOMAP this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FI | TUT | TAMPEREEN KORKEAKOULUSAATIO SR (HES) |
participant | LU | ITTM | INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA (PRC) |
participant | DK | LEO PHARMA | LEO PHARMA AS (PRC) |
participant | DK | COPSAC | DEN SELVEJENDE INSTITUTION DANSK BORNEASTMA CENTER (OTH) |
participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | UK | PFE | PFIZER LIMITED (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | DE | HS | HAHN-SCHICKARD-GESELLSCHAFT FUER ANGEWANDTE FORSCHUNG E.v. (REC) |
participant | AT | AIT | AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH (REC) |
participant | CH | CHUV | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (PUB) |
participant | DE | EURICE | EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH (PRC) |
coordinator | DE | CAU | CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (HES) |
participant | IE | TCD | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (HES) |
participant | DE | UDUS | HEINRICH-HEINE-UNIVERSITAET DUESSELDORF (HES) |
participant | DE | UKE | UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF (HES) |
participant | AT | UNIVIE | UNIVERSITAT WIEN (HES) |
participant | DE | TUM-MED | KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN (HES) |
participant | LU | uni.lu | UNIVERSITE DU LUXEMBOURG (HES) |
participant | EE | UTARTU | TARTU ULIKOOL (HES) |
participant | FI | UTA | TAMPEREEN YLIOPISTO (HES) |
participant | UK | LSHTM | LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER (HES) |
participant | UK | UNIVBRIS | UNIVERSITY OF BRISTOL (HES) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | DE | TUM | TECHNISCHE UNIVERSITAET MUENCHEN (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
Within the project ConcePTION this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | ORC | ORCION BV (PRC) |
participant | BE | Bionotus | BIONOTUS (PRC) |
participant | NL | ENTIS | STICHTING ENTIS (EUROPEAN NETWORK TERATOLOGY INFORMATION SERVICES) FOUNDATION (OTH) |
participant | BE | Synergist | THE SYNERGIST (OTH) |
participant | DK | Ellegaard | ELLEGAARD GOTTINGEN MINIPIGS AS (PRC) |
participant | BE | i-HD | THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA (REC) |
participant | IL | Teva | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | UK | MHRA | MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (PUB) |
participant | NL | Elevate | ELEVATE BV (PRC) |
participant | AT | BBMRI-ERIC | BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC) (REC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | NL | TTOP | TTOPSTART BV (PRC) |
participant | ES | FISABIO | FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | FI | THL | TERVEYDEN JA HYVINVOINNIN LAITOS (REC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | IE | EIWH | EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE (REC) |
participant | NL | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
participant | NL | LAREB | STICHTING LAREB (REC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | SE | SCC | REGION STOCKHOLM (PUB) |
participant | UK | NUTH | THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST (PUB) |
participant | IT | ARS | AGENZIA REGIONALE DI SANITA (OTH) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | IT | UNIFE | UNIVERSITA DEGLI STUDI DI FERRARA (HES) |
participant | UK | USWAN | SWANSEA UNIVERSITY (HES) |
participant | UK | SGUL | ST GEORGE'S HOSPITAL MEDICAL SCHOOL (HES) |
participant | UK | Ulster | UNIVERSITY OF ULSTER (HES) |
participant | ZA | UKZN | UNIVERSITY OF KWAZULU-NATAL (HES) |
participant | FR | CHUT | CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
coordinator | NL | UMC UTRECHT | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | CH | UNIGE | UNIVERSITE DE GENEVE (HES) |
participant | NO | UiO | UNIVERSITETET I OSLO (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | IT | CNR | CONSIGLIO NAZIONALE DELLE RICERCHE (REC) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | NL | RIVM | RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (REC) |
participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project EBiSC2 this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | FCDI | FUJIFILM CELLULAR DYNAMICS INC (PRC) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | UK | DH | Department of Health (REC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | BE | JAN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | BiP | BIONEER A/S (REC) |
participant | FR | ART | ARTTIC (PRC) |
participant | DK | LUB | H. LUNDBECK AS (PRC) |
participant | DK | NOVO | NOVO NORDISK A/S (PRC) |
participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
coordinator | DE | 01V FHG | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | Charité | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project Trials@Home this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | IQVIA | IQVIA RDS FRANCE (PRC) |
participant | BE | Covance | COVANCE CLINICAL AND PERIAPPROVAL SERVICES (PRC) |
participant | UK | MRN | MEDICAL RESEARCH NETWORK LIMITED (PRC) |
participant | UK | eClinicalHealth | ECLINICALHEALTH LTD (PRC) |
participant | NL | MLCF | STICHTING MLC FOUNDATION (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | IL | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | FR | DREEM | DREEM (PRC) |
participant | NL | UPPMD | STICHTING UNITED PARENT PROJECTS MUSCULAR DYSTROPHY (OTH) |
participant | UK | Allergan | ALLERGAN LIMITED (PRC) |
participant | BE | VT | VITAL TRANSFORMATION (PRC) |
participant | CH | Medtronic | MEDTRONIC INTERNATIONAL TRADING SARL (PRC) |
participant | ES | FISABIO | FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | NL | JCR | JULIUS CLINICAL RESEARCH BV (PRC) |
participant | NL | Lygature | STICHTING LYGATURE (OTH) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI Pharma | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
participant | AT | JOANNEUM | FH JOANNEUM GESELLSCHAFT MBH (HES) |
participant | CH | Novartis | NOVARTIS PHARMA AG (PRC) |
participant | DK | SDU | SYDDANSK UNIVERSITET (HES) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | BE | IDF Europe | FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL (OTH) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | NL | UU | UNIVERSITEIT UTRECHT (HES) |
Within the project INSPIRE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | NOTOCORD | NOTOCORD SYSTEMS (PRC) |
participant | NL | NCARDIA BV | NCARDIA BV (PRC) |
participant | DE | BI PHARMA GMBH | BOEHRINGER INGELHEIM PHARMA GMBH &CO KG (PRC) |
participant | DE | TSE | TSE SYSTEMS GMBH (PRC) |
participant | FR | INRIA | INSTITUT NATIONAL DE RECHERCHE ENINFORMATIQUE ET AUTOMATIQUE (REC) |
coordinator | BE | UA | UNIVERSITEIT ANTWERPEN (HES) |
participant | NL | UM | UNIVERSITEIT MAASTRICHT (HES) |
participant | UK | UNOTT | THE UNIVERSITY OF NOTTINGHAM (HES) |
participant | IL | WEIZMANN | WEIZMANN INSTITUTE OF SCIENCE (HES) |
Within the project IDEA-FAST this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | MBS | MEDIBIOSENSE LTD (PRC) |
participant | BE | BYTE | BYTEFLIES (PRC) |
participant | PT | FC.ID | FCIENCIAS.ID - ASSOCIACAO PARA A INVESTIGACAO E DESENVOLVIMENTO DE CIENCIAS (REC) |
participant | NL | MLCF | STICHTING MLC FOUNDATION (OTH) |
participant | IT | PLUR | PLURIBUS ONE SRL (PRC) |
participant | FR | DREEM | DREEM (PRC) |
participant | BE | EFCCA | EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS (OTH) |
participant | FI | VTT | Teknologian tutkimuskeskus VTT Oy (REC) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | DE | GHI | GEORGE-HUNTINGTON-INSTITUT GMBH (PRC) |
participant | US | ABBV | ABBVIE INC (PRC) |
participant | UK | BIOGEN | BIOGEN IDEC LIMITED (PRC) |
participant | UK | PUK | PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG (OTH) |
participant | FR | LIXOFT | LIXOFT SAS (PRC) |
participant | ES | APM | ASOCIACION PARKINSON MADRID (OTH) |
participant | NL | McR | MCROBERTS BV (PRC) |
participant | UK | TAK | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | UK | CCL | CAMBRIDGE COGNITION LIMITED (PRC) |
participant | NO | SUH | HELSE STAVANGER HF (OTH) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | PFE | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | PL | IPIN | INSTYTUT PSYCHIATRII I NEUROLOGII (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | UK | IXS | IXSCIENT LIMITED (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | DE | EMP | EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH (PRC) |
participant | IE | UL | UNIVERSITY OF LIMERICK (HES) |
participant | PT | IMM | INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES (REC) |
participant | DE | UKSH | UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN (HES) |
participant | UK | QMUL | QUEEN MARY UNIVERSITY OF LONDON (HES) |
participant | FR | IMT | INSTITUT MINES-TELECOM (HES) |
participant | AT | MUI | MEDIZINISCHE UNIVERSITAT INNSBRUCK (HES) |
participant | ES | UAM | UNIVERSIDAD AUTONOMA DE MADRID (HES) |
participant | IT | UNIBS | UNIVERSITA DEGLI STUDI DI BRESCIA (HES) |
participant | UK | UoM | THE UNIVERSITY OF MANCHESTER (HES) |
participant | SE | AZN | ASTRAZENECA AB (PRC) |
participant | UK | UGLAS | UNIVERSITY OF GLASGOW (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
coordinator | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | UK | ICL | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project PharmaLedger this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | PT | HES | HOSPITAL DO ESPIRITO SANTO DE EVORA EPE (PUB) |
participant | PT | INCM | IMPRENSA NACIONAL - CASA DA MOEDA, S. A. (PRC) |
participant | DE | BAYER | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | IL | AVO | ARTEEVO TECHNOLOGIES LTD (PRC) |
participant | US | ABBV | ABBVIE INC (PRC) |
participant | UK | TVS | TECHNOVATIVE SOLUTIONS LTD (PRC) |
participant | UK | ONO | ONORACH LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | DE | UKW | UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT (HES) |
participant | UK | PFE | PFIZER LIMITED (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
participant | IL | EKN | EKON MODELING SOFWARE SYSTEMS LTD*EKON (PRC) |
participant | IT | OPB | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | RO | INCDTCI ICSI | NATIONAL RESEARCH AND DEVELOPMENT INSTITUTE FOR CRYOGENICS AND ISOTOPIC TECHNOLOGIES ICSI RM VALCEA (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | EL | DUT | DIMOKRITIO PANEPISTIMIO THRAKIS (HES) |
participant | PT | PDM | PDM E FC PROJECTO DESENVOLVIMENTO MANUTENCAO FORMACAO E CONSULTADORIALDA (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | RO | RMS | ROMSOFT SRL (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | NOVO | NOVO NORDISK A/S (PRC) |
participant | SE | AZN | ASTRAZENECA AB (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
coordinator | ES | UPM | UNIVERSIDAD POLITECNICA DE MADRID (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |